Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00535626 · ClinicalTrials.gov registry record · NA
Trident® Tritanium™ Acetabular Shell Revision Study
A NA study, sponsored by Stryker Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
NCT00535626: Completed NA study, sponsored by Stryker Orthopaedics.
NCT00535626 is a NA study that has completed, run by Stryker Orthopaedics. The registered enrollment target is 241 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00535626, a NA study, has completed, sponsored by Stryker Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a hip implant system used when a previous hip replacement surgery has failed.
Interventions
- DEVICE Trident® Tritanium™ Acetabular Shell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2006-11 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT00535626 record still lists
NCT00535626 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Trident® Tritanium™ Acetabular Shell is the first listed.
NCT00535626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00535626 about?
NCT00535626 is a clinical study titled "Trident® Tritanium™ Acetabular Shell Revision Study". The purpose of this study is to evaluate a hip implant system used when a previous hip replacement surgery has failed.
What is the current status of trial NCT00535626?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2006-11. Estimated completion is 2016-09.
What interventions are being tested in trial NCT00535626?
The interventions under investigation include: Trident® Tritanium™ Acetabular Shell (DEVICE).
Who is sponsoring clinical trial NCT00535626?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00535626's enrollment target sits among peer trials
241 440th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia